These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 34806164)

  • 1. COVID-19 vaccine take-up rate and safety in adults with epilepsy: Data from a multicenter study in China.
    Lu L; Zhang Q; Xiao J; Zhang Y; Peng W; Han X; Chen S; Yang D; Sander JW; Zhou D; Xiong W
    Epilepsia; 2022 Jan; 63(1):244-251. PubMed ID: 34806164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 vaccination uptake in children with epilepsy and vaccine hesitancy among their parents: a survey.
    Lou D; Song Y; Li D; Shi Y; Wang B; Yang L
    Eur J Pediatr; 2024 Jun; 183(6):2763-2768. PubMed ID: 38558312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 vaccination hesitancy and safety among adult people with epilepsy in eastern China.
    Wang S; Lv J; He C; Yang Y; Zheng Y; Ye L; Chen C; Shen C; Xu S; Ding Y; Guo Y; Tang Y; Wang S; Ding M
    Epilepsy Behav; 2023 Jan; 138():108984. PubMed ID: 36423385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and tolerability of the novel 2019 coronavirus disease (COVID-19) vaccines among people with epilepsy (PwE): A cross-sectional study.
    Massoud F; Ahmad SF; Hassan AM; Alexander KJ; Al-Hashel J; Arabi M
    Seizure; 2021 Nov; 92():2-9. PubMed ID: 34391030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors and prevalence of COVID-19 vaccination in patients with focal epilepsy following resection surgery.
    Yang Y; Lv J; He C; Shen C; Xu S; Guo Y; Ding Y; Zheng Z; Zhu J; Wang S; Ding M; Wang S
    Epilepsy Behav; 2023 Aug; 145():109344. PubMed ID: 37459719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of COVID-19 vaccine on epilepsy in adult subjects: an Italian multicentric experience.
    Romozzi M; Rollo E; Quintieri P; Dono F; Evangelista G; Consoli S; Veleno L; Anzellotti F; Calvello C; Costa C; Servidei S; Calabresi P; Vollono C
    Neurol Sci; 2022 Aug; 43(8):4627-4634. PubMed ID: 35501537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.
    Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A
    Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV: A structured summary of a study protocol for a randomised controlled trial.
    Palacios R; Patiño EG; de Oliveira Piorelli R; Conde MTRP; Batista AP; Zeng G; Xin Q; Kallas EG; Flores J; Ockenhouse CF; Gast C
    Trials; 2020 Oct; 21(1):853. PubMed ID: 33059771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are COVID-19 vaccines safe for people with epilepsy? A cross-sectional study.
    Özdemir HN; Dere B; Gökçay F; Gökçay A
    Neurol Sci; 2022 Jun; 43(6):3489-3496. PubMed ID: 35224704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 vaccine in patients with Dravet syndrome: Observations and real-world experiences.
    Hood V; Berg AT; Knupp KG; Koh S; Laux L; Meskis MA; Zulfiqar-Ali Q; Perry MS; Scheffer IE; Sullivan J; Wirrell E; Andrade DM
    Epilepsia; 2022 Jul; 63(7):1778-1786. PubMed ID: 35383912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Technical guidelines for seasonal influenza vaccination in China (2021-2022)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) , Influenza Vaccination TWG
    Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Oct; 42(10):1722-1749. PubMed ID: 34814607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 vaccines in patients with decompensated cirrhosis: a retrospective cohort on safety data and risk factors associated with unvaccinated status.
    Cao Z; Zhang C; Zhao S; Sheng Z; Xiang X; Li R; Qian Z; Wang Y; Chen B; Li Z; Liu Y; An B; Zhou H; Cai W; Wang H; Gui H; Xin H; Xie Q
    Infect Dis Poverty; 2022 May; 11(1):56. PubMed ID: 35578350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors Associated With US Adults' Likelihood of Accepting COVID-19 Vaccination.
    Kreps S; Prasad S; Brownstein JS; Hswen Y; Garibaldi BT; Zhang B; Kriner DL
    JAMA Netw Open; 2020 Oct; 3(10):e2025594. PubMed ID: 33079199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between BNT162b2 Vaccination and Incidence of SARS-CoV-2 Infection in Pregnant Women.
    Goldshtein I; Nevo D; Steinberg DM; Rotem RS; Gorfine M; Chodick G; Segal Y
    JAMA; 2021 Aug; 326(8):728-735. PubMed ID: 34251417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 vaccine hesitancy in patients with systemic autoimmune rheumatic disease: an interview-based survey.
    Gaur P; Agrawat H; Shukla A
    Rheumatol Int; 2021 Sep; 41(9):1601-1605. PubMed ID: 34213580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of inactivated SARS-CoV-2 vaccines against the Delta variant infection in Guangzhou: a test-negative case-control real-world study.
    Li XN; Huang Y; Wang W; Jing QL; Zhang CH; Qin PZ; Guan WJ; Gan L; Li YL; Liu WH; Dong H; Miao YT; Fan SJ; Zhang ZB; Zhang DM; Zhong NS
    Emerg Microbes Infect; 2021 Dec; 10(1):1751-1759. PubMed ID: 34396940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of COVID-19 vaccination on epileptic seizures in patients with epilepsy: A clinical observation in China.
    Huang A; Lu Y; Ji J; Yao Y; Guan S; Chen Z; Yu L
    Hum Vaccin Immunother; 2022 Nov; 18(6):2141519. PubMed ID: 36412219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and immunogenicity of COVID-19 vaccination in patients with non-alcoholic fatty liver disease (CHESS2101): A multicenter study.
    Wang J; Hou Z; Liu J; Gu Y; Wu Y; Chen Z; Ji J; Diao S; Qiu Y; Zou S; Zhang A; Zhang N; Wang F; Li X; Wang Y; Liu X; Lv C; Chen S; Liu D; Ji X; Liu C; Ren T; Sun J; Zhao Z; Wu F; Li F; Wang R; Yan Y; Zhang S; Ge G; Shao J; Yang S; Liu C; Huang Y; Xu D; Li X; Ai J; He Q; Zheng MH; Zhang L; Xie Q; Rockey DC; Fallowfield JA; Zhang W; Qi X
    J Hepatol; 2021 Aug; 75(2):439-441. PubMed ID: 33905793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 vaccine-related frequently asked questions (FAQs) by people with epilepsy and carers in Iran; educational video is included.
    Asadi-Pooya AA; Karimi A; Razavizadegan SMA; Ashjazadeh N; Nemati H
    Epilepsy Behav; 2022 Aug; 133():108763. PubMed ID: 35696935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.